| (Values in U.S. Thousands) | Mar, 2026 | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 |
| Sales | 5,200 | 6,660 | 6,870 | 6,160 | 6,020 |
| Sales Growth | -21.92% | -3.06% | +11.53% | +2.33% | -3.22% |
| Net Income | 1,130 | -4,770 | 4,080 | -1,500 | -900 |
| Net Income Growth | +123.69% | -216.91% | +372.00% | -66.67% | -136.59% |
Phenixfin Corp Pr (PFX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
PhenixFIN Corporation is an internally managed, closed-end, business development company. It is focused on current income generation coupled with capital appreciation with a focus on net asset value. PhenixFIN Corporation, formerly known as Medley Capital Corporation, is based in New York.
Fiscal Year End Date: 09/30